XARELTO

Peak

rivaroxaban

NDAORALTABLET
Approved
Nov 2011
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1594

Clinical Trials (5)

NCT06355986N/ANot Yet Recruiting

Computerized Decision Support to Prevent Stroke in Atrial Fibrillation

Started Dec 2026
2,500 enrolled
Atrial FibrillationStroke
NCT05900388N/ANot Yet Recruiting

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

Started Sep 2026
850 enrolled
Venous ThromboembolismChildren Under 2 Years
NCT07029776Phase 2Not Yet Recruiting

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Started Jul 2026
50 enrolled
Multiple Myeloma (MM)
NCT07309445N/ARecruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Started Apr 2026
150 enrolled
Non-Muscle Invasive Bladder Neoplasms
NCT07228312N/ANot Yet Recruiting

A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms

Started Mar 2026
200 enrolled
Intracranial Aneurysm